Randomized Study of Two Interventions for Liquid Aspiration: Short-Term and Long-Term Effects
Launched by NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS (NIDCD) · Nov 2, 1999
Trial Information
Current as of March 21, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Have dementia or Parkinson's disease and are found to aspirate on thin liquid during a set of qualifying swallows.
- Exclusion Criteria:
- • Have smoked more than a pack of cigarettes per day in the last year.
- • Drink more than 3 alcoholic beverages per day on a regular basis.
- • Have had any head and neck cancer treatment.
- • Have any head and neck anatomic deformities.
- • Have a history of 20 years or longer of insulin-dependent diabetes.
- • Have other exclusionary neurologic diagnoses.
- • Have had pneumonia within 6 weeks of screening.
- • Currently have a nasogastric tube.
- • Currently have a tracheotomy.
- • Are a resident in non-participating nursing home or assisted living environment.
- • Live alone.
- • Have no regular care provider present at meals.
- • Have no Speech-Language Pathologist to provide a 3-month follow-up.
Trial Officials
Dr. Joanne Robbins
Study Chair
Dr. Jeri Logemann
Principal Investigator
About National Institute On Deafness And Other Communication Disorders (Nidcd)
The National Institute on Deafness and Other Communication Disorders (NIDCD) is a prominent agency within the National Institutes of Health (NIH) dedicated to advancing research and understanding of hearing, balance, taste, smell, voice, speech, and language disorders. Through rigorous clinical trials and innovative research initiatives, the NIDCD aims to improve the diagnosis, treatment, and prevention of communication disorders, ultimately enhancing the quality of life for individuals affected by these conditions. The institute fosters collaboration among researchers, healthcare professionals, and patients to translate scientific discoveries into effective clinical practices and public health strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madison, Wisconsin, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials